Idiopathic inflammatory myopathies

IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …

Update on outcome assessment in myositis

LG Rider, R Aggarwal, PM Machado… - Nature Reviews …, 2018 - nature.com
The adult and juvenile myositis syndromes, commonly referred to collectively as idiopathic
inflammatory myopathies (IIMs), are systemic autoimmune diseases with the hallmarks of …

Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEV1, exacerbations, oral corticosteroids, symptoms …

LP de Llano, I Dávila, E Martínez-Moragón… - The Journal of Allergy …, 2021 - Elsevier
Background There is a lack of tools to quantify the response to monoclonal antibodies
(mAbs) holistically in severe uncontrolled asthma patients. Objective To develop a valid …

Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis

RP Goswami, SN Haldar, M Chatterjee, P Vij… - Autoimmunity …, 2022 - Elsevier
Objective To perform a systematic review and meta-analysis on the efficacy and safety of
intravenous (IVIg) and subcutaneous (SCIg) immunoglobulin (Ig) therapy in the treatment of …

Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy

B Rockette-Wagner, D Saygin, S Moghadam-Kia… - …, 2021 - academic.oup.com
Abstract Objective Idiopathic inflammatory myopathies (IIMs) cause proximal muscle
weakness, which affects the ability to carry out the activities of daily living. Wearable physical …

Longitudinal observational study investigating outcome measures for clinical trials in inclusion body myositis

G Sangha, B Yao, D Lunn, I Skorupinska… - Journal of Neurology …, 2021 - jnnp.bmj.com
Objective To describe decline in muscle strength and physical function in patients with
sporadic inclusion body myositis (IBM). Methods Manual muscle testing (MMT), quantitative …

[HTML][HTML] Current Biomarker Strategies in Autoimmune Neuromuscular Diseases

M Oeztuerk, A Henes, CB Schroeter, C Nelke, P Quint… - Cells, 2023 - mdpi.com
Inflammatory neuromuscular disorders encompass a diverse group of immune-mediated
diseases with varying clinical manifestations and treatment responses. The identification of …

Updates on juvenile dermatomyositis from the last decade: classification to outcomes

H Kim, AM Huber, S Kim - Rheumatic Disease Clinics, 2021 - rheumatic.theclinics.com
Juvenile dermatomyositis (JDM) is a rare heterogeneous immune-medicated condition with
characteristic skin rashes, muscle weakness, vasculopathy, and other organ involvement …

Peculiar clinicopathological features of immune-mediated necrotizing myopathies

Y Allenbach, O Benveniste - Current opinion in rheumatology, 2018 - journals.lww.com
IMNM are muscle-specific autoimmune diseases associated with a severe weakness and a
risk poor muscle strength recovery. Anti-SRP and anti-HMGCR antibodies are specifically …

[HTML][HTML] Use of machine learning models to predict prognosis of combined pulmonary fibrosis and emphysema in a Chinese population

Q Liu, D Sun, Y Wang, P Li, T Jiang, L Dai… - BMC Pulmonary …, 2022 - Springer
Background Combined pulmonary fibrosis and emphysema (CPFE) is a novel clinical entity
with a poor prognosis. This study aimed to develop a clinical nomogram model to predict the …